| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 12 1283-1292, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
AA Dlugosz, C Cheng, MF Denning, PJ Dempsey, RJ Coffey Jr and SH Yuspa
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892.
Epidermal growth factor receptor (EGFR) ligands are fundamental regulators of epithelial growth, differentiation, and neoplastic transformation. In addition to being potent mitogens for murine epidermal keratinocytes in vitro, transforming growth factor alpha (TGF alpha) and EGF elicit distinctive changes in keratin expression: Ca(2+)-mediated induction of the differentiation-specific keratins K1 and K10 is blocked, while simple epithelial keratins K8 and K18 are expressed aberrantly (C. Cheng et al., Cell Growth, & Differ., 4: 317-327, 1993). We have evaluated several additional growth factors to determine the specificity of this response for EGFR ligands. TGF alpha, keratinocyte growth factor (KGF), and acidic fibroblast growth factor (aFGF), but not basic fibroblast growth factor (bFGF) or insulin-like growth factor type I, block Ca(2+)-mediated expression of K1 while inducing K8. Since KGF and aFGF (but not bFGF) are ligands for the KGF receptor (KGFR), we explored the possibility that the TGF alpha/EGFR pathway is an intermediary in signaling through the KGFR. TGF alpha mRNA was increased in cells treated with KGF, aFGF, or TGF alpha but not bFGF or insulin-like growth factor type I. Similar changes were detected at the protein level; TGF alpha in conditioned medium (CM) from control, KGF-, TGF alpha-, and aFGF-treated cultures was 54 (+/- 8, SEM), 365 (+/- 50), 146 (+/- 20), and 120 (+/- 50) pg/ml, respectively. KGF and TGF alpha also increased expression of cell-associated TGF alpha measured in keratinocyte lysates. KGF increased TGF alpha secretion and mRNA levels in human as well as mouse keratinocytes. CM from KGF-treated cultures stimulated cell growth when added to cultures of normal keratinocytes. Preincubation with neutralizing antibodies to both TGF alpha and KGF, but not KGF antibody alone, blocked cell growth in cultures treated with KGF CM, suggesting that the predominant keratinocyte mitogen in KGF CM is TGF alpha. In support of this hypothesis, treatment of keratinocytes for 5 min with either KGF CM or purified TGF alpha resulted in EGFR autophosphorylation. Furthermore, after approximately 24 h, KGF as well as TGF alpha induced EGFR down-regulation based on Western blot analysis and 125I-EGF binding. Induction of TGF alpha in KGF-treated keratinocytes, coupled to activation and down-modulation of the EGFR, suggests that TGF alpha may be a proximal effector of KGF action for at least certain aspects of epidermal growth and differentiation.
This article has been cited by other articles:
![]() |
A. Shukla, Y. Ho, X. Liu, A. Ryscavage, and A. B. Glick Cripto-1 Alters Keratinocyte Differentiation via Blockade of Transforming Growth Factor-{beta}1 Signaling: Role in Skin Carcinogenesis Mol. Cancer Res., March 1, 2008; 6(3): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Blijlevens and S Sonis Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis Ann. Onc., May 1, 2007; 18(5): 817 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis Cancer Res., April 1, 2004; 64(7): 2382 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Hicks Jr, L. A. Hall III, R. Hard, J. Gardella, F. Bright, N. Parasharama, J. Lwebuga-Mukasa, and L. Sigurdson Keratinocyte Growth Factor and Autocrine Repair in Airway Epithelium Arch Otolaryngol Head Neck Surg, April 1, 2004; 130(4): 446 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Atabai, M. Ishigaki, T. Geiser, I. Ueki, M. A. Matthay, and L. B. Ware Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L163 - L169. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Ware and M. A. Matthay Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L924 - L940. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Albanell, F. Rojo, S. Averbuch, A. Feyereislova, J. M. Mascaro, R. Herbst, P. LoRusso, D. Rischin, S. Sauleda, J. Gee, et al. Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition J. Clin. Oncol., January 1, 2002; 20(1): 110 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Capone, V. Visco, F. Belleudi, C. Marchese, G. Cardinali, M. Bellocci, M. Picardo, L. Frati, and M. R. Torrisi Up-Modulation of the Expression of Functional Keratinocyte Growth Factor Receptors Induced by High Cell Density in the Human Keratinocyte HaCaT Cell Line Cell Growth Differ., November 1, 2000; 11(11): 607 - 614. [Abstract] [Full Text] |
||||
![]() |
H. Ka, T. E. Spencer, G. A. Johnson, and F. W. Bazer Keratinocyte Growth Factor: Expression by Endometrial Epithelia of the Porcine Uterus Biol Reprod, June 1, 2000; 62(6): 1772 - 1778. [Abstract] [Full Text] |
||||
![]() |
J. DiGiovanni, K. Kiguchi, A. Frijhoff, E. Wilker, D. K. Bol, L. Beltran, S. Moats, A. Ramirez, J. Jorcano, and C. Conti Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice PNAS, March 28, 2000; 97(7): 3455 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Robles, M. L. Rodriguez-Puebla, A. B. Glick, C. Trempus, L. Hansen, P. Sicinski, R. W. Tennant, R. A. Weinberg, S. H. Yuspa, and C. J. Conti Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo Genes & Dev., August 15, 1998; 12(16): 2469 - 2474. [Abstract] [Full Text] |
||||
![]() |
P. Jaakkola, S. Kontusaari, T. Kauppi, A. Määttä, and M. Jalkanen Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes FASEB J, August 1, 1998; 12(11): 959 - 969. [Abstract] [Full Text] |
||||
![]() |
M. D. Hines and B. L. Allen-Hoffmann Keratinocyte Growth Factor Inhibits Cross-linked Envelope Formation and Nucleosomal Fragmentation in Cultured Human Keratinocytes J. Biol. Chem., March 15, 1996; 271(11): 6245 - 6251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Donjacour and G. Cunha Induction of prostatic morphology and secretion in urothelium by seminal vesicle mesenchyme Development, January 7, 1995; 121(7): 2199 - 2207. [Abstract] [PDF] |
||||
![]() |
P. T. La Celle and R. R. Polakowska Human Homeobox HOXA7 Regulates Keratinocyte Transglutaminase Type 1 and Inhibits Differentiation J. Biol. Chem., August 24, 2001; 276(35): 32844 - 32853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mason, M. C. Lewis, K. E. Edeen, K. McCormick-Shannon, L. D. Nielsen, and J. M. Shannon Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L249 - L258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |